β-Blockers Influence Oncological Outcomes in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Based on the Pathological Subtype: A Retrospective Cohort Study
This study suggests a differential impact of BB use on GC subtypes and underscores the importance of considering cancer subtypes and patient comorbidities when evaluating the potential benefits of BBs in cancer therapy.
Authors
- Fritz Brinkmann (ORCID: https://orcid.org/0000-0002-6663-0940)
- Nerma Crnovrsanin (ORCID: https://orcid.org/0009-0006-0036-9897)
- Georg Martin Haag (ORCID: https://orcid.org/0000-0002-9410-9968)
- Henrik Nienhüser (ORCID: https://orcid.org/0000-0002-0475-9538)
- Sabine Schiefer (ORCID: https://orcid.org/0000-0001-9430-8994)
- Ingmar F. Rompen (ORCID: https://orcid.org/0000-0002-0257-1654)
- Thomas Schmidt (ORCID: https://orcid.org/0000-0002-2772-8160)
- Thomas Longerich (ORCID: https://orcid.org/0000-0001-8888-1030)
- Leila Sisic (ORCID: https://orcid.org/0000-0003-1260-5771)
- Sebastian Zimmer (ORCID: https://orcid.org/0000-0002-1531-2088)
- Wenjun Hu (ORCID: https://orcid.org/0000-0001-8563-8844)
- Johanna Arnscheidt (ORCID: https://orcid.org/0000-0001-7277-2200)
- Mohammed Al‐Saeedi (ORCID: https://orcid.org/0000-0002-0583-4472)
- Sarah Zumsande
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1245/s10434-025-17233-9
- Citations
- 4
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- Heidelberger Stiftung Chirurgie
- Universitätsklinikum Heidelberg